Stay updated on HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the HER2+ Breast Cancer Clinical Trial page.

Latest updates to the HER2+ Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the page. The prior government-funding notice (Revision: v3.4.1) was removed.SummaryDifference0.3%

- Check21 days agoChange DetectedA site-wide funding notice was added and users are informed that information may not be up to date; the page version is updated to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedAdds a Show glossary toggle and updated metadata (Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0) while removing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data) and the prior Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedFooter now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.3.2 is now shown instead of v3.3.1. There are no changes to the study details, eligibility criteria, or locations.SummaryDifference0.0%

- Check92 days agoChange DetectedMinor editorial updates note that PubMed publications are automatically filled and that the revision number has changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2+ Breast Cancer Clinical Trial page.